Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic review
-
Published:2022-09
Issue:
Volume:172
Page:158-170
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Battisti Nicolò Matteo LucaORCID,
De Glas Nienke,
Soto-Perez-de-Celis Enrique,
Liposits GaborORCID,
Bringuier MichaelORCID,
Walko ChristineORCID,
Lichtman Stuart M.,
Aapro Matti,
Cheung Kwok-LeungORCID,
Biganzoli Laura,
Ring Alistair,
Portielje Johanneke,
Wildiers Hans,
Brain EtienneORCID
Subject
Cancer Research,Oncology
Reference49 articles.
1. The conundrum of the association of chemotherapy with survival outcomes among elderly patients with curable luminal breast cancer;Battisti;JAMA Oncol,2020
2. The effect of comorbidity on 3-year survival of women with primary breast cancer;Satariano;Ann Intern Med,1994
3. Biganzoli L, Battisti NML, Wildiers H, McCartney A, Colloca G, Kunkler IH, et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol. 2021 Jul;22(7):e327-e340. doi: https://doi.org/10.1016/S1470-2045(20)30741-5. Epub 2021 May 14. PMID: 34000244.
4. Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update;Andre;J Clin Oncol,2022
5. Individualizing adjuvant therapy in women with hormone receptor-positive, human epidermal growth factor receptor 2-negative node-positive breast cancer;Gogineni;JCO Oncol Pract,2022
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献